Optics.org
daily coverage of the optics & photonics industry and the markets that it serves
Featured Showcases
Photonics West Showcase
Laser World of Photonics Showcase
Press Releases
Menu
Press Release

PicoQuant Invests in FluoBrick Solutions to Simplify Access to Single Molecule Research

Date Announced: 23 Sep 2025

Partnering to make advanced fluorescence techniques intuitive, affordable, and accessible

PicoQuant GmbH announces its investment in FluoBrick Solutions GmbH, a newly founded Berlin-based start-up focused on giving life science researchers in academia and pharma diagnostics access to the power of single molecule techniques.

Founded in 2025 as a spin-off from Ludwig-Maximilians-Universität München (LMU Munich), FluoBrick Solutions removes barriers to highly sensitive methods like Fluorescence Correlation Spectroscopy (FCS) and Förster Resonance Energy Transfer (FRET), enabling researchers to advance protein and oligonucleotide characterization. Its first product, the Brick, complements common fluorescence methods by offering a single-molecule perspective at picomolar concentrations, saving valuable sample material and preparation time while helping researchers to verify their results and accelerate workflows.

I am really thrilled to build on the outcomes of my PhD project, to enable scientists to gain faster and deeper insights into complex protein interactions and single-particle detection without the need for significant investment or prior expertise in advanced fluorescence methods,” says Dr. Gabriel Moya, Founder of FluoBrick Solutions. “This allows them to better characterize molecular interactions and conformational changes, which are key to unlocking new discoveries in biomedical and life science research.”

In 2022, PicoQuant introduced Luminosa, a single-photon counting confocal microscope that pairs outstanding data quality with remarkable simplicity, lowering the barrier to advanced single-molecule methods. With a ready-to-use FCS and FRET instrument, FluoBrick Solutions now enables researchers without prior expertise in single-molecule methods to study molecular kinetics.

Image: Rainer Erdmann from PicoQuant (middle), Dr. Gabriel Moya (right) and Prof. Dr. Thorben Cordes (left) from FluoBrick Solutions seal their partnership to jointly foster innovation in single-molecule research.

 

Contact

PicoQuant GmbH
Nicole Saritas
Marketing Communications
Tel.: +49-30-1208820-607
marketing@picoquant.com
www.picoquant.com

E-mail: marketing@picoquant.com

Web Site: www.picoquant.com

 
© 2025 SPIE Europe
Top of Page